XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding XBiotech Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 50 | 53 | +3 |
| Shares | 4.85M | 4.72M | −135.4K (−2.8%) |
| Value | $37.5M | $18.6M | −$18.9M (−50.3%) |
New holders (10)
Institutions that held XBiotech Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deutsche Bank AG | 30,338 | $119.8K | 0.00% |
| Virtu Financial LLC | 14,735 | $58.0K | 0.00% |
| Susquehanna International Group, LLP | 12,768 | $50.4K | 0.00% |
| Group One Trading, L.P. | 7,500 | $29.6K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 6,328 | $25.0K | 0.00% |
| Jones Financial Companies LLLP | 1,577 | $6.23K | 0.00% |
| GAMMA Investing LLC | 151 | $596 | 0.00% |
| Citadel Advisors LLC | 13 | $51 | 0.00% |
| IFP Advisors, Inc | 2 | $8 | 0.00% |
| SBI Securities Co., Ltd. | 1 | $4 | 0.00% |
Sold out (7)
Institutions that held XBiotech Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| UBS Asset Management Americas Inc | 253,770 | $1.96M |
| Price T Rowe Associates Inc | 23,625 | $183.0K |
| MetLife Investment Management | 12,157 | $94.0K |
| Jane Street Group, LLC | 11,141 | $86.1K |
| Simplex Trading, LLC | 159 | $1.00K |
| Smartleaf Asset Management LLC | 84 | $605 |
| Capital Performance Advisors LLP | 1 | $8 |